82 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
(MMF) and low-dose glucocorticoids alone. Additionally, the updated label now requires quarterly, rather than monthly kidney function assessment after
8-K
EX-99.1
7mjom7 i5p
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
S-3ASR
EX-4.3
s96cje3cmx5l6 z5
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
ccw268
19 Nov 21
Automatic shelf registration
5:04pm
8-K
EX-99.1
qcsxv62jiqkuwddes4e4
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
DEF 14A
bclzlrzq
10 May 21
Definitive proxy
4:06pm
PRE 14A
yqqhmtpfvv ys9g
27 Apr 21
Preliminary proxy
4:32pm
10-K
8ekekjc
24 Feb 21
Annual report
4:09pm
10-K
EX-10.6
wacyhh1
24 Feb 21
Annual report
4:09pm
10-K
EX-10.7
sx1 qeg8ronidjk0u
24 Feb 21
Annual report
4:09pm
10-K
EX-10.8
noek9sy vf578
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
e6rcgkvce 5eo
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.2
311s43
10 Nov 20
Current report (foreign)
4:05pm